Aldebaran Capital, LLC
Source: SEC Form 13F · as of Mar 2026Aldebaran Capital, LLC holds 10 biotech & pharma companies tracked by BioSniper, totaling $19.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$19.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 9,007 | $8.3M |
| ACRSAclaris Therapeutics, Inc. | 947,162 | $3.6M |
| AMLXAmylyx Pharmaceuticals, Inc. | 197,892 | $2.8M |
| MOHMolina Healthcare Inc | 12,608 | $1.7M |
| TECXTectonic Therapeutic, Inc. | 37,184 | $1.1M |
| KZRKezar Life Sciences, Inc. | 80,335 | $596K |
| PMVPPMV Pharmaceuticals, Inc. | 473,362 | $587K |
| AVIRAtea Pharmaceuticals, Inc. | 89,946 | $484K |
| OKUROnKure Therapeutics, Inc. | 40,419 | $167K |
| IMAImageneBio, Inc. | 18,566 | $93K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.